1YC5 image
Deposition Date 2004-12-21
Release Date 2005-04-26
Last Version Date 2024-11-20
Entry Detail
PDB ID:
1YC5
Keywords:
Title:
Sir2-p53 peptide-nicotinamide
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.40 Å
R-Value Free:
0.20
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:NAD-dependent deacetylase
Gene (Uniprot):cobB
Chain IDs:A
Chain Length:246
Number of Molecules:1
Biological Source:Thermotoga maritima
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Cellular tumor antigen p53 peptide
Chain IDs:B
Chain Length:18
Number of Molecules:1
Biological Source:
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ALY B LYS N(6)-ACETYLLYSINE
Primary Citation
Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
Mol.Cell 17 855 868 (2005)
PMID: 15780941 DOI: 10.1016/j.molcel.2005.02.022

Abstact

Sir2 enzymes form a unique class of NAD(+)-dependent deacetylases required for diverse biological processes, including transcriptional silencing, regulation of apoptosis, fat mobilization, and lifespan regulation. Sir2 activity is regulated by nicotinamide, a noncompetitive inhibitor that promotes a base-exchange reaction at the expense of deacetylation. To elucidate the mechanism of nicotinamide inhibition, we determined ternary complex structures of Sir2 enzymes containing nicotinamide. The structures show that free nicotinamide binds in a conserved pocket that participates in NAD(+) binding and catalysis. Based on our structures, we engineered a mutant that deacetylates peptides by using nicotinic acid adenine dinucleotide (NAAD) as a cosubstrate and is inhibited by nicotinic acid. The characteristics of the altered specificity enzyme establish that Sir2 enzymes contain a single site that participates in catalysis and nicotinamide regulation and provides additional insights into the Sir2 catalytic mechanism.

Legend

Protein

Chemical

Disease

Primary Citation of related structures